Technology
Health
Pharmaceutical

Xeris Pharmaceuticals

$11.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (0.50%) Today
$0.00 (0.00%) As of 4:33 PM EDT after-hours

Why Robinhood?

You can buy or sell XERS and other stocks, options, ETFs, and crypto commission-free!

About XERS

Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSolâ„¢ and XeriJectâ„¢ formulation technologies. Read More The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Austin, TX.

Employees
90
Headquarters
Chicago, Illinois
Founded
2005
Market Cap
319.87M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
127.71K
High Today
$12.07
Low Today
$11.57
Open Price
$11.94
Volume
65.43K
52 Week High
$27.98
52 Week Low
$6.85

Collections

Technology
Health
Pharmaceutical
2018 IPO
US
North America

XERS Earnings

-$1.07
-$0.95
-$0.83
-$0.71
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.93 per share
Actual
Expected Aug 12, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.